<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: RedX Pharma shares rally 29% on research collaboration with Jazz Pharmaceuticals	</title>
	<atom:link href="https://ukinvestor.foxrobinson.com/redx-pharma-shares-rally-29-on-research-collaboration-with-jazz-pharmaceuticals/feed/" rel="self" type="application/rss+xml" />
	<link>https://ukinvestor.foxrobinson.com/redx-pharma-shares-rally-29-on-research-collaboration-with-jazz-pharmaceuticals/</link>
	<description></description>
	<lastBuildDate>Fri, 02 Oct 2020 14:46:42 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.6.3</generator>
	<item>
		<title>
		By: Advanced Oncotherapy progresses towards &#039;democratising proton therapy&#039; - UK Investor Magazine		</title>
		<link>https://ukinvestor.foxrobinson.com/redx-pharma-shares-rally-29-on-research-collaboration-with-jazz-pharmaceuticals/#comment-16010</link>

		<dc:creator><![CDATA[Advanced Oncotherapy progresses towards &#039;democratising proton therapy&#039; - UK Investor Magazine]]></dc:creator>
		<pubDate>Fri, 02 Oct 2020 14:46:42 +0000</pubDate>
		<guid isPermaLink="false">https://ukinvestor.foxrobinson.com/?p=30880#comment-16010</guid>

					<description><![CDATA[[&#8230;] Oncotherapy (AIM:AVO), developer of proton therapy systems for cancer treatment, recently announced several areas of progress which will help realise its goal of [&#8230;]]]></description>
			<content:encoded><![CDATA[<p>[&#8230;] Oncotherapy (AIM:AVO), developer of proton therapy systems for cancer treatment, recently announced several areas of progress which will help realise its goal of [&#8230;]</p>
]]></content:encoded>
		
			</item>
	</channel>
</rss>
